Carlos Bagley, MD
Neurological Surgery · Kansas City, MONPI 1801939947
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $529,108 of the $532,452 with a category attached, or 99.4%. Stryker accounts for 99.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $172,238 and has fallen 99.8% since, to $424 in 2025. Among neurological surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $21,298 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$529K
- Synthes GmbH$2K
- Medical Device Business Services, Inc.$424
- Medacta USA, Inc.$339
- Medtronic$105
Across 7 payments — averaging $7951.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$34K
- Mitsubishi Tanabe Pharma Development America, Inc.$14K
- Tanabe Pharma America, Inc.$8K
What the payments were for
- Royalty or licence$529,10899%
- Speaking & faculty fees$1,5000%
- Travel & lodging$1,6240%
- Food & beverage$2200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 13 | $529,108 |
| Synthes GmbH | 3 | $2,477 |
| Medical Device Business Services, Inc. | 4 | $424 |
| Medacta USA, Inc. | 1 | $339 |
| Medtronic(2 entities) | 4 | $105 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- YUKON OCT SPINAL SYSTEM$343,239
- YUKON$185,869
- MYSPINE$339
- Velys$309
How this compares
$532,452 in reported general payments places this provider in the 95th percentile of 172 neurological surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 156 | $789 |
| Methocarbamol | 45 | $520 |
| Tizanidine Hcl | 48 | $321 |
| Gabapentin | 39 | $306 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $117 |
| Tramadol Hcl | 32 | $76 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Kansas City
- Stephen GriffithKansas City$8K
- Stephen ReintjesKansas City$6K
- Neill WrightSaint Louis$1.1M
- Wilson RaySaint Louis$586K
- Kaywan GamadiaCape Girardeau$458K
- Camilo MolinaSaint Louis$412K
- Paul SantiagoSaint Louis$368K
- Daniel ScodarySaint Louis$278K
- Daniel HafezSaint Louis$273K
- John OgunladeSaint Louis$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.